Pressure BioSciences (PBIO) Narrows Q1 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts PBIO Hot Sheet
Price: $0.00 --0%
Financial Fact:
Warrant income relating to revaluation: 623.13K
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Financial Fact:
Warrant income relating to revaluation: 623.13K
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Pressure BioSciences, Inc. (Nasdaq: PBIO) reported Q1 loss of ($0.34), $0.02 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $181 thousand versus the consensus estimate of $280 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- American Express (AXP) Tops Q3 EPS by 84c, Misses on Revenue, Raises FY Guidance
- Flagstar Financial, Inc. (FLG) Misses Q3 EPS by 6c
- Balchem Corp. (BCPC) Tops Q3 EPS by 14c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
